Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R. Bosse(Children's Hospital of Philadelphia), John M. Maris(Children's Hospital of Philadelphia), Maria Lane(Children's Hospital of Philadelphia), Robyn T. Sussman(University of Pennsylvania), Doncho V. Zhelev(National Cancer Institute), Javed Khan(Kent State University), A. Sorana Morrissy(Hospital for Sick Children), Daniel Martínez(Children's Hospital of Philadelphia), Michael P. Randall(Dartmouth College), Jun S. Wei(Center for Cancer Research), Laura Donovan(Hospital for Sick Children), Mariarita Santi(Children's Hospital of Philadelphia), Komal S. Rathi(Children's Hospital of Philadelphia), Bruce Pawel(University of Southern California), Gonzalo López(Icahn School of Medicine at Mount Sinai), Tricia Bhatti(Children's Hospital of Philadelphia), Pichai Raman(Children's Hospital of Philadelphia), Sabine Heitzeneder(Stanford University), Marco A. Marra(University of British Columbia), Arupa Ganguly(University of Pennsylvania), Crystal L. Mackall(Parker Institute for Cancer Immunotherapy), Dimiter S. Dimitrov(University of Pittsburgh), Michael D. Taylor(Hospital for Sick Children), Jennifer Hwang(National Cancer Institute), Zhongyu Zhu(Frederick National Laboratory for Cancer Research), Yang Feng(National Cancer Institute), Yanping Wang(Central South University), Jo Lynne Harenza(Children's Hospital of Philadelphia), Nathan M. Kendsersky(Children's Hospital of Philadelphia)
Cited by 229
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k